{"id":"https://openalex.org/W2149172133","doi":"https://doi.org/10.1124/dmd.107.016345","title":"High-Throughput Radiometric CYP2C19 Inhibition Assay Using Tritiated (S)-Mephenytoin","display_name":"High-Throughput Radiometric CYP2C19 Inhibition Assay Using Tritiated (S)-Mephenytoin","publication_year":2007,"publication_date":"2007-06-29","ids":{"openalex":"https://openalex.org/W2149172133","doi":"https://doi.org/10.1124/dmd.107.016345","mag":"2149172133","pmid":"https://pubmed.ncbi.nlm.nih.gov/17600081"},"language":"en","primary_location":{"id":"doi:10.1124/dmd.107.016345","doi":"https://doi.org/10.1124/dmd.107.016345","is_oa":false,"landing_page_url":"https://doi.org/10.1124/dmd.107.016345","pdf_url":null,"source":{"id":"https://openalex.org/S145039780","display_name":"Drug Metabolism and Disposition","issn_l":"0090-9556","issn":["0090-9556","1521-009X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism and Disposition","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064210998","display_name":"Annalise Di Marco","orcid":"https://orcid.org/0000-0001-5211-6230","observed_orcids":["https://orcid.org/0000-0001-5211-6230"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annalise Di Marco","raw_affiliation_strings":["Department of Pharmacology, Istituto di Recherche di Biologia Molecolare, Merck Research Laboratories, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Istituto di Recherche di Biologia Molecolare, Merck Research Laboratories, Rome, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111073084","display_name":"Antonella Cellucci","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antonella Cellucci","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010220206","display_name":"Ashok Chaudhary","orcid":"https://orcid.org/0000-0002-3884-786X","observed_orcids":["https://orcid.org/0000-0002-3884-786X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ashok Chaudhary","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076006178","display_name":"Massimiliano Fonsi","orcid":"https://orcid.org/0000-0003-4549-1483","observed_orcids":["https://orcid.org/0000-0003-4549-1483"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Massimiliano Fonsi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111594821","display_name":"Ralph Laufer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ralph Laufer","raw_affiliation_strings":["Merck & Co"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":1.2138,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.75381878,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"35","issue":"10","first_page":"1737","last_page":"1743"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyp2c19-inhibition","display_name":"CYP2C19 inhibition","score":0.9940000176429749},{"id":"https://openalex.org/keywords/s-mephenytoin-4-hydroxylation","display_name":"S-mephenytoin 4'-hydroxylation","score":0.9380000233650208},{"id":"https://openalex.org/keywords/radiometric-assay","display_name":"radiometric assay","score":0.8119999766349792},{"id":"https://openalex.org/keywords/high-throughput-screening","display_name":"high-throughput screening","score":0.777999997138977},{"id":"https://openalex.org/keywords/human-liver-microsomes","display_name":"human liver microsomes","score":0.8970000147819519},{"id":"https://openalex.org/keywords/nih-shift","display_name":"NIH shift","score":0.7789999842643738},{"id":"https://openalex.org/keywords/solid-phase-extraction","display_name":"solid-phase extraction","score":0.7570000290870667},{"id":"https://openalex.org/keywords/drug-drug-interaction-prediction","display_name":"drug-drug interaction prediction","score":0.6140000224113464}],"concepts":[{"id":"https://openalex.org/C2776838488","wikidata":"https://www.wikidata.org/wiki/Q1175385","display_name":"Mephenytoin","level":5,"score":0.8227484822273254},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8028550148010254},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.7305580377578735},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.6312975287437439},{"id":"https://openalex.org/C2781109383","wikidata":"https://www.wikidata.org/wiki/Q898497","display_name":"Hydroxylation","level":3,"score":0.5881556272506714},{"id":"https://openalex.org/C2780000105","wikidata":"https://www.wikidata.org/wiki/Q424236","display_name":"Tritiated water","level":3,"score":0.533560037612915},{"id":"https://openalex.org/C62538594","wikidata":"https://www.wikidata.org/wiki/Q54389","display_name":"Tritium","level":2,"score":0.51017165184021},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.26931583881378174},{"id":"https://openalex.org/C140840227","wikidata":"https://www.wikidata.org/wiki/Q3737532","display_name":"CYP2C19","level":4,"score":0.2579629123210907},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1791439950466156},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.1761159896850586},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.16000065207481384},{"id":"https://openalex.org/C185544564","wikidata":"https://www.wikidata.org/wiki/Q81197","display_name":"Nuclear physics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D001189","descriptor_name":"Aryl Hydrocarbon Hydroxylases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D001189","descriptor_name":"Aryl Hydrocarbon Hydroxylases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D001189","descriptor_name":"Aryl Hydrocarbon Hydroxylases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006899","descriptor_name":"Mixed Function Oxygenases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D006899","descriptor_name":"Mixed Function Oxygenases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006899","descriptor_name":"Mixed Function Oxygenases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008617","descriptor_name":"Mephenytoin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011874","descriptor_name":"Radiometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014316","descriptor_name":"Tritium","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D014867","descriptor_name":"Water","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065731","descriptor_name":"Cytochrome P-450 CYP2C19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1124/dmd.107.016345","doi":"https://doi.org/10.1124/dmd.107.016345","is_oa":false,"landing_page_url":"https://doi.org/10.1124/dmd.107.016345","pdf_url":null,"source":{"id":"https://openalex.org/S145039780","display_name":"Drug Metabolism and Disposition","issn_l":"0090-9556","issn":["0090-9556","1521-009X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism and Disposition","raw_type":"journal-article"},{"id":"pmid:17600081","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17600081","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug metabolism and disposition: the biological fate of chemicals","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.849.840","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.849.840","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://dmd.aspetjournals.org/content/35/10/1737.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.6240000128746033,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1537014667","https://openalex.org/W1889057977","https://openalex.org/W1924733673","https://openalex.org/W1956507658","https://openalex.org/W1977389135","https://openalex.org/W1985137752","https://openalex.org/W1986838867","https://openalex.org/W2002124497","https://openalex.org/W2003237988","https://openalex.org/W2012407966","https://openalex.org/W2029083358","https://openalex.org/W2040106948","https://openalex.org/W2043130168","https://openalex.org/W2045397804","https://openalex.org/W2059293500","https://openalex.org/W2061108237","https://openalex.org/W2064648180","https://openalex.org/W2067778052","https://openalex.org/W2075180687","https://openalex.org/W2091003207","https://openalex.org/W2097141281","https://openalex.org/W2097502628","https://openalex.org/W2110975307","https://openalex.org/W2140023920","https://openalex.org/W2151430007","https://openalex.org/W2161976213","https://openalex.org/W2163536623","https://openalex.org/W2170016489","https://openalex.org/W2170202887","https://openalex.org/W2246028378","https://openalex.org/W2399510505","https://openalex.org/W2401995582","https://openalex.org/W2410495908","https://openalex.org/W6641004201","https://openalex.org/W6676516507","https://openalex.org/W6680791999","https://openalex.org/W6837124653"],"related_works":["https://openalex.org/W2170016489","https://openalex.org/W1974652632","https://openalex.org/W2097141281","https://openalex.org/W4255347352","https://openalex.org/W2094578084","https://openalex.org/W2120907197","https://openalex.org/W2401995582","https://openalex.org/W2074114811","https://openalex.org/W2081961567","https://openalex.org/W1995366070"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}